News tagged with “novartis ag”. Found:
29 tagged news reports.
Your Search Returned 29 tagged news reports
Prospecting for Stocks: Novartis
Alexandria :: VA :: USA | 13 days ago
Credibility
Identifying the best investment opportunities in the sector takes time. So we've built this "Prospecting" screen -- which is a simplified version of the special checklist that has helped Jeff Fischer and the Motley Fool Pro team -- to accelerate your...
Tags: Novartis AG, Alexandria, Novartis, Business Finance, The Motley Fool
Novartis Terminates Pact With Idera
Zurich :: Switzerland | 14 days ago
Credibility Idera Pharmaceuticals said early Wednesday that Novartis AG plans to terminate the companies' collaboration agreement on Feb. 21, 2010. The pact focused on the development of potential treatments for asthma and allergies. As a result of the termination,...
Tags: Idera Pharmaceuticals Inc., Novartis AG, Switzerland, Zurich, Health Medical Pharma, Novartis, Pharmaceutical industry in China, Pharmaceuticals policy, Allergy, Business Finance, Asthma, Pharmaceutical companies, Merck & Co.
Novartis: Smaller Flu-vaccine Doses Suffice
Basel :: Switzerland | 22 days ago
Credibility Novartis AG, the Basel health-care giant, on Tuesday reported progress from clinical trials of its influenza A (H1N1) vaccine. In clinical trials, a single dose of the vaccine, which is half the currently approved U.S. dose, "fulfilled immune-response...
Tags: Novartis AG, U.S, h1n1 vaccine, Switzerland, Basel, Influenza vaccine, Immunology, flu pandemic vaccine, Novartis, Swine influenza, Vaccines, Pandemics, Influenza, Health Medical Pharma, Influenza vaccines, H5N1, Vaccination, Prevention, Influenza research, Influenza A virus subtype H1N1, Vaccine
Novartis to Boost China Presence
Zurich :: Switzerland | about 1 month ago
Credibility This copy is for your personal, non-commercial use only...Novartis AG said Wednesday it plans to buy a majority stake in privately held Chinese vaccines maker Zhejiang Tianyuan for around $125 million, as the Swiss drug maker seeks to boost its presence...
Tags: Novartis Swine-Flu Vaccine Approved, Novartis AG, Germany
Novartis invests $1B for R&D in China
Shanghai :: China | about 1 month ago
Credibility Swiss pharmaceutical group Novartis said Tuesday that it would invest $1 billion dollars in research and development (R&D) in China to latch on to growing demand for health care. Shanghai, which specializes in basic research and developing new drugs,...
Tags: China, Novartis AG
Focusing on key swine flu issues
Basel :: Switzerland | about 1 month ago
Credibility Federal officials Wednesday urged against panic and asked for patience as the government works to distribute H1N1 vaccines and contain the spread of the virus. Here are answers to some common questions about H1N1, known as swine flu, and the government's...
Tags: swine flu, flu vaccinate, U.S, Novartis AG, h1n1 vaccinate, United States, million vaccinate
Novartis Posts 1 Percent Growth in Third Quarter Profits
Zurich :: Switzerland | about 1 month ago
Credibility Drug maker Novartis AG posted Thursday a 1 percent increase in third-quarter net profit on strong sales of pharmaceuticals, such as its new Afinitor drug against kidney cancer, as well as its swine flu vaccines. The profit of $2.1 billion was up from...
Tags: Novartis AG, swine flu, flu vaccines, net profitable, quarter net, net income
Investors Business Daily: Human Genome Sciences gets $75M from Novartis
Zurich :: Switzerland | about 1 month ago
Credibility Human Genome Sciences Inc. said Monday it will be paid $75 million by Swiss drugmaker Novartis AG for successful clinical testing of the hepatitis C drug candidate Zalbin. The companies plan to file for U.S. and European regulatory approval in the fourth...
Tags: Human Genome Sciences, Novartis AG
Vanda Licenses Schizophrenia Drug To Novartis
Tel Aviv :: Israel | about 1 month ago
Credibility Vanda Pharmaceuticals Inc., the Rockville, Md., drugmaker, licensed the right to commercialize and develop Fanapt in the U.S. and Canada to Novartis. Fanapt, generically iloperidone, is a schizophrenia treatment approved by the U.S...In statements late...
Tags: Vanda Pharmaceuticals Inc., U.S, Novartis AG
Novartis buys global rights to antibiotic candidate
Zurich :: Switzerland | 2 months ago
Credibility Novartis will share responsibility to develop the drug, called PTK 0796, with privately held Boston, Massachusetts-based company Paratek Pharmaceuticals...Citi currently expects first sales in 2013 and sees Novartis expanding the clinical trials programme...
Tags: Paratek Pharmaceuticals of Boston, Paratek Pharmaceuticals...Citi, Paratek Pharmaceuticals Inc., Novartis AG, upfront payments, Switzerland, Zurich
Site Links
Site Topics
Contributions
- Report Your News
- Add your voice and contribute via your cellphone - check out how to Report News via Your Cellphone
- Blog Widget
- Widget for Blog Owner
